SKI Market

Indian Indices

Nifty

24,967.75 97.65
(0.39%)

Sensex

81,635.91 329.06
( 0.40%)

Bank Nifty

55,139.30 -10.10
( -0.02%)

Nifty IT

36,280.10 839.25
( 2.37%)

Global Indices

Nasdaq

45,658.64 852.13
(1.90%)

Dow Jones

6,488.44 97.27
(1.52%)

Hang Seng

42,789.96 156.67
(0.37%)

Nikkei 225

9,321.40 12.20
(0.13%)

Forex

USD-INR

87.17 0.12
(0.14%)

EUR-INR

101.39 0.01
(0.01%)

GBP-INR

117.16 -0.12
(-0.11%)

JPY-INR

0.59 0.00
(-0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

100.3479373

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

24.13

1703.26

EPS(TTM)

Face Value()

Div & Yield %

6.69

0.31

Back

gennex laboratories ltd

Kedia Construction Company reports standalone net loss of Rs 0.04 crore in the June 2025 quarter

Aug 08,2025

Net loss of Kedia Construction Company reported to Rs 0.04 crore in the quarter ended June 2025 as against net profit of Rs 0.01 crore during the previous quarter ended June 2024. Sales remain constant at Rs 0.06 crore in the quarter ended June 2025 and also during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	0.06	0.06	0
OPM %	-83.33	33.33	-
PBDT	-0.05	0.02	PL
PBT	-0.05	0.02	PL
NP	-0.04	0.01	PL

24,967.75 97.65 (0.39%)

81,635.91 329.06 ( 0.40%)

55,139.30 -10.10 ( -0.02%)

36,280.10 839.25 ( 2.37%)

45,658.64 852.13 (1.90%)

6,488.44 97.27 (1.52%)

42,789.96 156.67 (0.37%)

9,321.40 12.20 (0.13%)

87.17 0.12 (0.14%)

101.39 0.01 (0.01%)

117.16 -0.12 (-0.11%)

0.59 0.00 (-0.18%)